Interferon Zeta-Like Precursor, encoded by the Gm13276 gene, plays a pivotal role in the body's innate immune response, serving as a crucial component in the defense against viral infections and various pathogens. This protein is integral to the production of interferons and other antiviral molecules, orchestrating a complex network of immune responses to combat invading microorganisms. Its function primarily revolves around the recognition of viral elements and the initiation of signaling pathways that ultimately lead to the expression of interferons, which serve as potent antiviral effectors. The activation of Interferon Zeta-Like Precursor is orchestrated through an intricate web of molecular pathways that sense and respond to viral infections. One key mechanism involves the recognition of viral components by Toll-like receptors (TLRs), specifically TLR3 and TLR7. When viral molecules are detected, TLR activation triggers downstream signaling cascades, leading to the activation of Interferon Zeta-Like Precursor. This activation is further amplified through the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, which is initiated by cytokines such as interferon-alpha (IFN-α). These cytokines indirectly enhance the activation of Interferon Zeta-Like Precursor by suppressing negative regulators of interferon signaling.
Another significant pathway involved in Interferon Zeta-Like Precursor activation is the retinoic acid-inducible gene I (RIG-I) signaling pathway. RIG-I receptors recognize viral RNA, subsequently initiating a signaling cascade that promotes the expression of Interferon Zeta-Like Precursor. Additionally, the modulation of mitochondrial antiviral-signaling protein (MAVS) activity and the disruption of MAVS-NLRP3 interactions can indirectly influence Interferon Zeta-Like Precursor activation, highlighting the complexity and adaptability of the immune response against viral threats. In summary, Interferon Zeta-Like Precursor (Gm13276) stands as a vital guardian of the body's innate immune defense system, orchestrating the production of interferons and other antiviral molecules upon encountering viral infections. Its activation relies on a diverse range of signaling pathways, including TLR activation, JAK-STAT signaling, and RIG-I pathway activation, each contributing to the effective response against viral pathogens. Understanding the intricate mechanisms by which this protein operates provides valuable insights into the body's innate immunity and its ability to combat viral invaders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
Imiquimod, a TLR7 agonist, stimulates TLR7, leading to the activation of Interferon Zeta-Like Precursor via NF-κB signaling. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $650.00 | 2 | |
Poly(I:C), an IRF3 activator, stimulates IRF3 phosphorylation and nuclear translocation, enhancing Interferon Zeta-Like Precursor expression. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $96.00 $166.00 $459.00 $1615.00 | 12 | |
LPS, an NF-κB activator, activates the NF-κB pathway, resulting in the transcriptional upregulation of Interferon Zeta-Like Precursor. | ||||||
Amlexanox | 68302-57-8 | sc-217630 | 10 mg | $160.00 | 2 | |
Amlexanox, a TBK1 activator, enhances the phosphorylation of TBK1, promoting the activation of IRF3 and Interferon Zeta-Like Precursor. | ||||||
IKK Inhibitor X | 431898-65-6 | sc-221742 | 5 mg | $345.00 | 3 | |
IKK Inhibitor X stimulates the IKK complex, leading to NF-κB activation and subsequent Interferon Zeta-Like Precursor expression. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $100.00 $300.00 $500.00 $1528.00 | 12 | |
R-848, a TLR7 agonist, activates TLR7, leading to the activation of Interferon Zeta-Like Precursor via NF-κB signaling. | ||||||
BX 795 | 702675-74-9 | sc-281689 sc-281689A sc-281689C sc-281689B sc-281689D sc-281689E | 2 mg 5 mg 10 mg 25 mg 50 mg 100 mg | $219.00 $273.00 $331.00 $495.00 $882.00 $1489.00 | 5 | |
BX-795, a TBK1 activator, enhances the phosphorylation of TBK1, promoting the activation of IRF3 and Interferon Zeta-Like Precursor. | ||||||